Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

ACIU

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in AC Immune SA

Yes. JPMorgan Chase holds 7,798 shares of ACIU (AC Immune), worth $20,743, as of its Q2 2026 13F filing. It increased the position by 158 shares (+2.1%) from Q1 2026. JPMorgan Chase has held ACIU in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$20,743

Current Shares

7,798

Total Value Change

-$19,688

Total Shares Change

-2,898

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,798
+2.1%
$20,7430.0%$2.38
13
2026-Q1
Decreased
7,640
-12.4%
$19,5580.0%$2.91
0
2025-Q4
Increased
8,721
+20.1%
$27,3840.0%$3.15
16
2025-Q3
Increased
7,259
+18.8%
$20,9790.0%$3.04
15
2025-Q2
Decreased
6,110
-14.0%
$12,4030.0%$2.01
0
2025-Q1
Decreased
7,107
-15.6%
$13,2900.0%$1.98
0
2024-Q4
Decreased
8,424
-21.2%
$22,7450.0%$2.70
0
2024-Q3
First report
10,696
-
$40,4310.0%$3.78
0

Other major holders of ACIU: Temasek Holdings (Private) Ltd, Duquesne Family Office LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used